radiosurgeryindia1@gmail.com +91 9884334290

Dr.Dutta’s Profile

  1. Fellowship in Stereotactic conformal radiotherapy (SCRT) in brain tumour; Intensity modulated radiotherapy (IMRT) in head and neck cancer and was senior registrar at Tata Memorial Hospital, Mumbai.
  2. Twenty-five PUBMED indexed full-length paper and twenty peer reviewed international abstracts.
  3. Presenter in International society of pediatrics (SIOP) meeting at Mumbai in 2008, ASCO Merit award winner at Chicago in 2008, presenter at World Federation of Neurooncology (WFNO) ‘Hoshino’ Younger investigator award at Japan in 2009, European CyberKnife Protocol development meeting (EPDC) at Nice in 2010 and Radiosurgery annual meeting at San Francisco in 2011; International Physics meeting at Dhaka, 2011 and SAARC oncology meeting in Bhutan, 2011; invited speaker on role of radiotherapy in prostate cancer at 5th International Urology conference at Dhaka, 2012; presenter at ESTRO 2013, Geneva on ‘CyberKnife treatment in liver metastasis: Indian experience’; invited speaker at ASNO meeting on ‘Quality of life issues’ at Mumbai, March 2013. Presenter ASCO 2014, Chicago, Proton beam therapy users meeting 2014, Paris.
  4. Co-author of three books (‘Glioma overviews’ published by AMRI Hospital, Kolkata, India in 2006 and ‘Complications of radiotherapy’ by Tata Memorial Hospital, Mumbai, India as EBM 2009 and ‘Role of radiotherapy in urological malignancies in 2011 with Dr MA Salam, Dhaka). Invited reviewer of indexed journals. Editor of radiosurgery website: radiosurgery-india.com
  5. Invited speaker about CyberKnife and oncology in more than 100 meetings in India and abroad.
  6. Abroad training in robotic radiosurgery at Antoine Lacassagne Cancer Centre, Nice and Oscar Lambret Cancer Centre, Lille, France in radiosurgery in GI malignancies and brain tumour. CyberKnife training at Munich CyberKnife Centre, Munich, Germany.
  7. ‘Neucletron Fellowship award’ in AROICON 2010 at Patna, India.
  8. At present (Enrolment no: 13PhD115 at VIT University, Vellore) as PhD candidate at VIT, Vellore. Thesis topic is on molecular prognostication of head & neck cancer.
  1. Graduation: M.B.B.S, University of Calcutta, India. (1993-1999)
  2. Post-graduation: M. D. in Radiotherapy, University of Calcutta, India, (2003-2006)
  3. Research Fellow in Stereotactic radiotherapy in neurooncology, Intensity Modulated Radiotherapy in head & neck cancer, senior registrar in Radiation Oncology at Tata Memorial Hospital, Mumbai (2006-2010).
  4. Abroad training in robotic radiosurgery at Antoine Lacassagne Cancer Centre, Nice; Oscar Lambret Cancer Centre, Lille, France and at Munich CyberKnife Centre, Munich, Germany in radiosurgery treatment in GI malignancies and brain tumour.
  5. At present (2013 registered candidate) external PhD candidate at VIT, Vellore. Thesis topic is on molecular prognostication of head & neck cancer.
  1. Prestigious ‘Neucletron Fellowship’ award by AROI, India in 2010
  2. Presenter in World Federation of Neurooncology (WFNO) for ‘Hoshino’ young investigator award at Yokohama, Japan 2009.
  3. Recipient of American Society of Clinical Oncology (ASCO) ‘Merit award’ in Chicago, USA in 2008.
  4. Best poster presentation in AROICON 2005 and 2nd best paper presentation in AROI Kolkata chapter in 2006.
  1. Oral and poster presentation in World Federation of Neurooncology (WFNO) Yokohama, Japan 2009. ‘Detailed prospective neuropsychological, activity of daily living and endocrine function assessment in children with craniopharyngioma treated with stereotactic conformal radiotherapy’.
  2. Presenter and ‘Merit Award’ winner of American Society of Clinical Oncology

(ASCO) annual meeting 2008 in Chicago, USA. “Prospective analysis of endocrine function in children with residual/recurrent low grade brain tumours treated with high precision stereotactic conformal radiotherapy.”

  1. Abstract accepted for presentation in American Brachytherapy Association (ABS) annual meeting 2008 in Boston, USA. “External beam radiotherapy and interstitial implant boost in early oral cavity cancer: experience of 23 cases from a new brachytherapy centre.”
  2. Oral presentation in International Society of Pediatrics (SIOP) annual meeting 2007 in Mumbai, India. “Prospective analysis of incidence of central nervous system tumours in pediatric patients presenting in a tertiary cancer hospital from India.”
  3. Attended the European CyberKnife protocol development meeting at Nice, France on September 2010.
  4. Presenter at CyberKnife users meeting at San Francisco, USA on 2011.
  5. Invited speaker about CyberKnife in International Physics meeting, Dhaka and SAARC oncology meeting, Bhutan, 2011.
  6. Invited speaker on role of radiotherapy in prostate cancer at 5th International Urology conference at Dhaka, 2012.
  7. Invited speaker at AROICON 2012 at Kolkata on CyberKnife in GI malignancies.
  8. Presenter ESTRO 2013, Geneva on ‘CyberKnife treatment in liver metastasis: Indian experience’.
  9. Invited speaker at ASNO meeting on ‘Quality of life issues’ at Mumbai, March 2013.
  10. Presenter ASCO 2014, Chicago
  11. Participant, Proton beam therapy users meeting, Paris 2014
  12. Invited speaker International Head & Neck meeting, Dhaka 2014
  1. Indian Society of Neurooncology (ISNO); Neurological society of India (NSI); Association of Radiation Oncologists of India (AROI). CyberKnife Society; ESTRO.
  1. Efficacy of stereotactic conformal radiotherapy (SCRT) compared to conventional radiotherapy in minimizing late sequelae in children and young adults with brain tumours: A randomized clinical trial.
  2. Prospective randomized control trial between 3DCRT versus IMRT in locally advanced head and neck cancers.
  3. Concurrent Temozolomide and radical radiotherapy in brainstem glioma: prospective study of 20 cases.
  4. An Open Label, Prospective, Multicentric study to evaluate the safety and efficacy of Nimotuzumab (BIOMAb-EGFRTM) As Induction and Maintenance Therapy In combination with Radiotherapy plus Temozolomide (Concomitant & Adjuvant) in Indian patients with Glioblastoma.
  5. Prospective evaluation of setup errors with different head supports in brain tumour.
  6. Tomotherapy for locally advanced buccal mucosa tumors as a method of dose escalation.
  7. Preoperative concurrent chemo-radiation in locally advanced inoperable gallbladder and pancreatic cancers treated with Tomotherapy: A Phase II feasibility study.
  1. Jalali R, Mullick I, Dutta D, et al. Age and radiotherapy doses to left temporal lobe predict neurocognitive outcomes in young patients with benign and low grade brain tumours: data from a prospective trial of stereotactic conformal radiation therapy. Int J Radiat Oncol Biol phys 2010; 77(4):974-9 [PMID: 19864079].
  2. Jalali R, Raut N, Gupta T, Arora B, Dutta D, Kurkure P, Sarin R. Phase II prospective study on children with newly diagnosed diffuse intrinsic pontine brain stem gliomas treated with concurrent and adjuvant Temozolomide with radiotherapy. Int J Radiat Oncol Biol phys 2010; 77(1):113-8 [PMID 19647954]
  3. Jalali R, Dutta D, Srinivas C, et al. Encouraging experience of micromultileaf collimator based stereotactic radiosurgery for carefully selected arteriovenous malformations. J Cancer Res Ther 2009;5(3):186-91 [PMID: 19841560]
  4. Budrrukar A, Jalali R, Dutta D, et al. Prospective Quality of Life assessment using EORTC QLQ 30 and brain cancer module (BN 20) in 257 consecutive adult patients with primary brain tumours in a typical Neuro-Oncology clinic in India. J Neurooncol 2010; 95(3):413-9 [PMID: 19548070]
  5. Dutta D, Lee H, Munshi A, et al. Intracerebral Cystic Rhabdoid meningioma- A case report. J Clin Neurosci 2009; 16: 1073–1074 [PMID: 19427788]
  6. Dutta D, Vanere P, Gupta T, et al. Factors influencing activities of daily living using FIM-FAM scoring system before starting adjuvant treatment in patients with brain tumors: results from a prospective study. J Neurooncol. 2009; 94(1):103-10.[PMID: 19255726]
  7. Dutta D, Munshi A, Gupta T, et al. Pituitary Adenoma Neuronal Choristoma: The PANCH Syndrome. Acta Oncologica, 2008; 19:1-3 [PMID:18607864].
  8. Jalali R, Dutta D, Kamble R, et al. Prospective assessment of activities of daily living using Modified Barthel’s scoring system in children with low-grade gliomas treated with stereotactic conformal radiotherapy. J Neurooncol 2008; 90(3):321-8.[PMID: 18704269]
  9. Budrukkar A, Dutta D, Sharma D, et al. Comparison of geometric uncertainties using Electronic Portal Imaging Device in focal 3 -Dimensional Conformal Radiation Therapy using different head supports. J Cancer Res Ther 2008; 4( 2): 71-77 [PMID:18688122]
  10. Jalali R and Datta D.Prospective analysis of incidence of central nervous system tumours presenting in a tertiary cancer hospital from India. J Neurooncol 2008; 87:111–114 PMID:18004503<
  11. Munshi A, Dutta D, Muzumdar D, et al. An atypical presentation of recurrent meningioma with external auditory canal mass. Indian J Cancer 2007 ;44 (3): 119-21[PMID:18250535]
  12. Mohanty A, Dutta D, Das S, et al. Skull metastasis from carcinoma cervix: a rare case and review of literature. J Gyn Oncol Res 2010; 36 (2): 441-443 [PMID:19841560].
  13. Agarwal JP, Dutta D, Palwe V, et al. Prospective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation. J Cancer Res Ther 2010; 6(1):15-21 [PMID:20479541]
  14. Munshi A, Dutta D, Kakkar S, et al. Comparison of early quality of life in patients treated with radiotherapy following mastectomy or breast conservation therapy: a prospective study. Radiother Oncol June 1 2010 [PMID: 20627431]
  15. Munshi A, Talapatra K, Dutta D. Breast cancer radiotherapy and cardiac risk. Oncol Reviews 2010; 4(3):137-146
  16. Agarwal JP, Palwe V, Dutta D, et al. Prospective subjective and objective evaluation and assessment of functional and anatomical components of swallowing dysfunctions. Dysphagia 2011[PMID:21344191]
  17. Mohanty A, Dutta D, Senapati SN et al. Carcinoma oesophagus with acral metastasis. Indian Journal of Cancer 2011 [PMID:20492404]
  18. Dutta D, Centhil V, Munshi A, et al.Spontaneous regression of optic pathway glioma, When to intervene? J Cancer Res Ther 2011 [PMID: 21358114]
  19. Dutta D, Balaji S, Kurup PG et al. Dosimetric comparison of CyberKnife and BrainLAB in acaustic schwannoma. J NeuroOncol 4th Sep 2011[PMID:21892741]
  20. Jalali R, Dutta D. Factors influencing Quality of life in adult primary brain tumour. Neurooncology 2012.[PMID: 23095834]
  21. Munshi A, Dutta D, Budrukkar A et al. Photon energy in breast cancer radiation therapy management. J Cancer Res Ther 2012[PMID:23174715]
  22. Goda JS, Dutta D, Raut N, Juvekar SL, Purandare N, Rangarajan V, Arora B, Gupta T, Kurkure P, Jalali R. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A Report from a Prospective Phase-II Study. Pediatr Neurosurg. 2013;49(5):274-81.[PMID: 25277867]
  23. Sarkar BK, Chakraborty C, Sharma AR, Bae KJ, Sharma G, Doss GP, Dutta D, Ding S, Ganbold B, Nam JS, Lee SS. Novel biomarker for prostate cancer diagnosis by MRS. Front Biosci (Landmark Ed). 2014;19:1186-201.[PMID:24896344]
  24. Dutta D, Balaj S, Sudhar V et al. Robotic radiosurgery experience in liver tumours from an Indian Centre. Indian J Cancer 2014 (In press)
  25. Gupta T, Dutta D, Trivedi S, Upasani M, Jalali R, Sarin R. Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas. J Cancer Res Ther. 2010 Jul-Sep;6(3):272-7. doi: 10.4103/0973-1482.73353 PMID: [21119252]
  26. Budrukkar A, Jalali R, Dutta D, Sarin R, Devlekar R, Parab S, Kakde A. Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol. 2009 Dec;95(3):413-9. doi: 10.1007/s11060-009-9939-8 [PMID:19548070]
  1. Dutta D, Shah N, Gupta T, et al. Prospective analysis of endocrine function in children with residual/recurrent low grade brain tumours treated with high precision stereotactic conformal radiotherapy. J Clin Oncol 26:2008 (May 20 Suppl; abstr 2049)
  2. Dutta D, Biswas LN, Roy C, et al. External Beam Radiotherapy and Interstitial Implant Boost in Early Oral cavity Cancer: Experience of 23 cases from a new brachytherapy centre. Brachytherapy (7) 2008; 61-71:163 (Abstr 74)
  3. Dutta D, Gupta T, Munshi A, et al. Detailed prospective neuropsychological, activity of daily living and endocrine function assessment in children with craniopharyngioma treated with stereotactic conformal radiotherapy. Neurooncology (WFNO 11th May 2009, Japan)
  4. Jalali R, Dutta D, Goswami S, et al. Neuropsychological profile in children with low-grade brain tumours before starting treatment with focal RT: baseline data from an ongoing randomised trial. Neurooncol; Oct 2007: 588.
  5. Jalali R, Dutta D, Develekar R, et al. Prospective assessment of ADL using Barthel’s scoring system in children with low grade brain tumours treated with SCRT. Pediatric Blood Cancer 49 (4) October 2007: 430.
  6. Jalali R, Raut N, Gupta T, Arora B, Kurkure P, Dutta D, Sarin R. Clinical and radiological correlation in children with newly diagnosed intrinsic brain stem gliomas treated with concurrent and adjuvant Temozolomide with radiotherapy: data from a prospective clinical trial. Eur J Cancer 2008.
  7. Ghosh-Laskar S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Dutta D et al. Phase II study of 3-Dimensional Conformal Radiotherapy (3D-CRT) vs Intensity Modulated Radiotherapy (IMRT) for Squamous Cell Carcinoma of the Head and Neck (HNSCC): A Preliminary Report. (Varian annual meeting)
  8. Jalali R, Dutta D, Mullick I, et al. Age and radiotherapy doses to left temporal lobe predict neurocognitive outcomes in young patients with benign and low grade brain tumours: data from a prospective trial of stereotactic conformal radiation therapy. Neurooncology (WFNO 11th May 2009, Japan)
  9. Dutta D, Mahadev P, Kurup PG et al. Dosimetric comparison of IMRT, SBRT and HDR brachytherapy in node negative hypopharyngeal cancer. CK Society meeting, San Francisco 2011.
  10. Dutta D, Mishra P, Sudahar V et al. Robotic radiosurgery in opthalmological conditions. ASNO Annual meeting, Mumbai 2013.
  11. Dutta D, Balaj S, Sudhar V et al. Robotic radiosurgery experience in liver tumours from an Indian Centre. ESTRO, Geneva 2013.
  12. Sathiya K, Dutta D, Mahadev P et al. Robotic radiosurgery experience in AVM from an Indian Centre. Indian Cancer Congress, Delhi 2013.
  13. Rakesh Jalali, Uday Krishna, Tejpal Gupta, Savita Goswami, Joyita Deodhar, Debnarayan Dutta, Sadhna Kannan, Atul Goel, Rajiv Sarin. Long-term prospective neuro-psychological outcomes and survival in children with progressive benign/low-grade brain tumours treated with high-precision stereotactic conformal radiation therapy. JCO 2014 Abstr 2050
  1. Invited speaker in Neurological Society of India (NSI) annual conference, Pune 2009; Indian Society of Neurooncology (ISNO) annual conference New Delhi 2009 & Chennai 2010, Kolkata 2011; International Physics meeting at Dhaka, 2011 and SAARC oncology meeting in Bhutan, 2011, 5th International Conference on Urology at Dhaka, 2012.
  2. Invited speaker in more than eighty CMEs on “Whole body Radiosurgery’ various meetings (CMEs) in various cities in India, Bangladesh, Myanmar, Bhutan, Nepal, Dubai.
  3. Honorary reviewer in peer reviewed indexed medical journal ‘Rare tumors’ published by Mayo Clinic, USA; NeJM and others.
  4. Co-author of Evidence based management 2009 book published by Tata Memorial Hospital, Mumbai, India (ISBN No 978-81-904583-8-2). Chapter: ‘CNS complications of radiation therapy’. Co-author of book on ‘Overview on Glial Cell Tumor’; July 2006. Edited by K Bhattacharya and D Dutta. Published by AMRI Cancer Center, Kolkata, India. Co-author of chapter on ‘Role of radiotherapy in urological malignancies’ with Dr MA Salam edited book ‘Urological malignancies’.
  5. Special interest in website preparation. Helped in updating and redesigning brain tumour foundation website in April 2007 (braintumourindia.com) for Tata Memorial Hospital and Brain Tumour Foundation of India. Editor of neurosurgery website: www.neurosurgery-india.com

I have special interest in statistical analysis, trial protocol design and preparation of SPSS in data maintenance. I have interest in quality of life and radiation therapy induced complication research. Also have interest in high precision radiation therapy techniques including stereotactic radiotherapy, brain tumor and head and neck cancer. Have special interest in whole body stereotactic radiosurgery (SBRT).

Dr. Debnarayan Dutta MD, Senior Consultant and Head, Radiation Oncology, Amrita Institute of Medical Sciences, Peeliyadu Road, Ponekkara, Edappally, Ernakulam, Kerala – 682041

+91-484-2853056

+91 9884334290

radiosurgeryindia1@gmail.com

Download Dr.Dutta’s Profile in PDF